0 CHECKOUT

Specialty Injectables: Ten Key Markets to 2020

  • ID: 2823016
  • May 2014
  • 63 Pages +
  • Greystone Associates
1 of 3

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

Highlights

- Analyzes therapeutic demand drivers and evaluates specialty injectables in ten major therapeutic markets

- Analyzes design factors, material selection issues, technologies and market development issues

- Assess significant managed care, technology, and regulatory factors affecting specialty injectable drug markets.

- Provides market data and forecasts to 2020

Note: Product cover images may vary from those shown
2 of 3

1. Executive Summary

2. Anticoagulants

3. Antivirals

4. Autoimmune Diseases

5. Multiple Sclerosis

6. Diabetes

7. Hematopoietics

8. Hormone Replacement

9. Migraine

10. Osteoporosis

11. Reproductive Health

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pall Corporation
  • Ferring Pharmaceuticals B.V.
  • Medtronic, Inc.
  • SkyePharma AG
  • Heron Therapeutics, Inc.
  • NIPRO Medical Corporation